Jennifer L Taylor-Cousar
22PUBLICATIONS
45CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (22)
Sort by Publication Date:
|Feb 27, 2026
Improving survival in CF across the globe requires more than improved CFTR modulator access alone.Jennifer L Taylor-Cousar
|Oct 22, 2025
Design and characterization of 4D-710, an aerosolized gene therapy for cystic fibrosis lung disease.Melissa A Calton, Roxanne H Croze, Theodore H Sullivan
|Sep 17, 2025
Long-term reductions in inflammation in people with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor.Scott D Sagel, T Spencer Poore, Brandie D Wagner
|Aug 11, 2025
Impact of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Tolerance and Abnormal Glucose Metabolism: A Phase 3b, Open-Label Clinical Trial.Isabelle Durieu, Barry Clements, Benedetta Fabrizzi
|Jun 02, 2025
Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Children ≥6 Years with Cystic Fibrosis and at Least One F508del Allele: A 192-Week, Phase 3, Open-Label Extension Study.Claire Wainwright, Susanna A McColley, Paul McNally
|Jan 15, 2025
The impact of highly effective modulator therapy on sinusitis and dysosmia in young children with cystic fibrosis: a prospective study protocol.Christine M Liu, Jakob L Fischer, Edith T Zemanick
Pageof 4
Frequent Collaborators
5 joint publications
Marcus A Mall
3 joint publications
Traci M Kazmerski
3 joint publications
Edward McKone
2 joint publications
Matthias Griese
2 joint publications
Felix C Ringshausen
2 joint publications
Natalie E West
2 joint publications
Stephen M Humphries
1 joint publications
Nicholas J Withers
1 joint publications
Anna M Georgiopoulos
1 joint publications
Daniel M Beswick
